» Articles » PMID: 36525706

Exosomes Based Strategies for Brain Drug Delivery

Overview
Journal Biomaterials
Date 2022 Dec 16
PMID 36525706
Authors
Affiliations
Soon will be listed here.
Abstract

Exosome application has emerged as a promising nanotechnology discipline for various diseases therapeutics and diagnoses. Owing to the natural properties of efficient drug delivery, higher biocompatibility, facile traversing of physiological barriers, and subtle side effects, exosomes shorten their way to clinical translation. Exosomes are nanoscale membrane-bound vesicles primarily involved in intercellular communication and exhibit natural blood-brain barrier (BBB) traversing ability, which enables their application as drug delivery vehicles for brain diseases treatment. Herein, we highlight recent exosome-based drug delivery endeavors for neurodegenerative diseases and brain cancer therapy, summarize the obstacles and future directions in clinical translation.

Citing Articles

Exosomal miR-203 from bone marrow stem cells targets the SOCS3/NF-κB pathway to regulate neuroinflammation in temporal lobe epilepsy.

Wang W, Yin J World J Stem Cells. 2025; 17(2):101395.

PMID: 40061262 PMC: 11885937. DOI: 10.4252/wjsc.v17.i2.101395.


Exosomal Bupivacaine: Integrating Nerve Barrier Penetration Capability and Sustained Drug Release for Enhanced Potency in Peripheral Nerve Block and Reduced Toxicity.

Cai Y, Li Q, Wesselmann U, Zhao C Adv Funct Mater. 2025; 34(42).

PMID: 40027274 PMC: 11870390. DOI: 10.1002/adfm.202406876.


Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins.

Chen Y, Qi W, Wang Z, Niu F Pharmaceutics. 2025; 17(2).

PMID: 40006514 PMC: 11858990. DOI: 10.3390/pharmaceutics17020147.


Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.


Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.

PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.